These are the stakes: a five-day treatment with Remdesivir costs around $3,000. A five-day supply of generic HCQ costs around $10. Drug companies have every right to recoup their cost of research and development, but lobbying to suppress access to a life-saving treatment that is both cheaper and more effective is a crime against humanity.
